J&J buys cancer drugmaker Halda for $3bn in latest biotech deal | Curated by Alerts360

Pharma group hopes acquisition will help to offset losses from expiring patents on blockbuster drugs | Get real-time financial updates, market trends, and investment insights delivered directly to you.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0